janpix logo

Janpix Inc.

Janpix Inc. develops and manufactures biopharmaceutical for cancer treatment. It is discovering and developing inhibitors of signal transducer and activator of transcription (STAT) proteins to target different body compartments affected with cancer.

[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”MXF.L” api=”yf” style=”font-size: 15px”]

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.janpixbio.com
Founded2017
Disease Focus
Development Stage
STOCK CODELON: MXF
Address
Cambridge Innovation CenterOne Broadway, 14th FloorCambridge, MA 02142,MA,,United States
Cambridge
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/janpix-limited” connections=”true” suffix=””]